The retinoblastoma tumour-suppressor protein (pRb) and p300/CBP co-activato
r proteins are important for control of proliferation and in tumour cells t
hese are sequestered by viral oncoproteins such as E1A, pRb is involved in
negatively regulating growth, and p300/CBP proteins have histone acetyltran
sferase (HAT) activity, which influences gene expression. Although it is kn
own that phosphorylation by G1 cyclin-dependent kinases (CDKs) regulates pR
b activity, the nature and role of other post-translational modifications i
s not understood. Here we identify acetylation as a new type of modificatio
n and level of control in pRb function. Adenovirus E1A, which binds p300/CB
P through an amino-terminal transformation-sensitive domain, stimulates the
acetylation of pRb by recruiting p300 and pRb into a multimeric-protein co
mplex. Furthermore, pRb acetylation is under cell-cycle control, and acetyl
ation hinders the phosphorylation of pRb by cyclin-dependent kinases, pRb b
inds more strongly when acetylated to the MDM2 oncoprotein, which indicates
that acetylation may regulate protein-protein interactions in the pRb path
way. The acetylation of pRb defines a new level of cell-cycle control media
ted by HAT. Furthermore, our results establish a relationship between p300,
pRb and acetylation in which E1A acts to recruit and target a cellular HAT
activity to pRb.